Metabolic Determinants of Hematopoietic Cell Development

Wright, Daniel G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project (R01)
• Project #: 1R01HL054072-01A1
• Application #: 2232281
• Study Section: Hematology Subcommittee 2 (HEM)
• Project Start: 1996-08-01
• Project End: 2000-07-31
• Budget Start: 1996-08-01
• Budget End: 1997-07-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Boston University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 604483045
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02118

Publications

Malek, Karim; Boosalis, Michael S; Waraska, Kristin et al. (2004) Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies. Leuk Res 28:1125-36

Wright, Daniel G; Boosalis, Michael; Malek, Karim et al. (2004) Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies. Leuk Res 28:1137-43

Wright, D G; Boosalis, M S; Waraska, K et al. (1996) Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis. Anticancer Res 16:3349-51